You are here: vision-research.eu » News » Newsdetails:
At Hawaiian Eye 2022, Nancy Lurker, president and CEO of EyePoint Pharmaceuticals, discusses data from the Phase 1 DAVIO study of EYP-1901 for wet-AMD.
